Penghao Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Penghao Guo has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Yaqin Peng
Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University
5 shared publicationsJingchun Fang
Department of Clinical Laboratory, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
3 shared publicationsKang Liao
Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
2 shared publications- Kang Liao
Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
2 shared publications Weihong Lin
Department of Clinical Laboratory, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou, China
2 shared publicationsAilifeire Ainiwaer
Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in BMC Microbiology
Twelve-year surveillance identifies parent B Candida orthopsilosis causing breakthrough candidemia during caspofungin therapy with echinocandin heteroresistance
Background: Echinocandin breakthrough infection can occur despite conventional susceptibility results that do not indicate resistance, suggesting that population-level minimum inhibitory concentration (MIC) testing may miss clinically relevant within-isolate heterogeneity. Most clinical Candida orthopsilosis isolates are hybrids, whereas parent B has previously been represented only by marine isolates despite evidence of pathogenic potential and echinocandin fitness. It remains unknown whether parent B can contribute to invasive infection under echinocandin exposure and whether conventional susceptibility testing adequately captures its antifungal response. Results: We analysed C. orthopsilosis bloodstream isolates recovered at a tertiary hospital in Guangzhou, within the coastal Pearl River Delta of southern China, from 2010 to 2021. Among 197 C. parapsilosis species-complex isolates, 17 were confirmed as C. orthopsilosis , including six bloodstream isolates. Nuclear and mitochondrial genome analyses assigned one highly homozygous isolate, BS03, to parent B, a lineage previously represented only by marine isolates. A blood culture yielding BS03 was collected after 12 days of ongoing caspofungin therapy. The patient developed septic shock and died two days later. In a Galleria mellonella model, BS03 showed pathogenic potential without significantly greater virulence than the tested fungal comparators. Its caspofungin MIC was 0.5 mg/L, within the wild-type range. Population analysis profiling nevertheless detected resistant subpopulations at 2, 4, and 8 mg/L caspofungin, corresponding to 4×, 8×, and 16× MIC, respectively. BS03 thus fulfilled the predefined criterion for caspofungin heteroresistance. Comparison of GSC1 ( FKS1 ), GSL1 , and GSL2 identified no BS03-specific canonical Fks1 hot spot resistance substitution. Conclusions: These findings extend the known clinical spectrum of C. orthopsilosis parent B beyond its previously recognised marine context. The coexistence of a wild-type-range caspofungin MIC with a resistant minority population further highlights within-isolate heterogeneity as an additional dimension of echinocandin susceptibility that may be missed by population-level MIC testing. Clinical trial number: Not applicable.
- 31 October 2026
- Published by Springer Nature in BMC Microbiology
Open AccessTwelve-year surveillance identifies parent B Candida orthopsilosis causing breakthrough candidemia during caspofungin therapy with echinocandin heteroresistance
Background: Echinocandin breakthrough infection can occur despite conventional susceptibility results that do not indicate resistance, suggesting that population-level minimum inhibitory concentration (MIC) testing may miss clinically relevant within-isolate heterogeneity. Most clinical Candida orthopsilosis isolates are hybrids, whereas parent B has previously been represented only by marine isolates despite evidence of pathogenic potential and echinocandin fitness. It remains unknown whether parent B can contribute to invasive infection under echinocandin exposure and whether conventional susceptibility testing adequately captures its antifungal response. Results: We analysed C. orthopsilosis bloodstream isolates recovered at a tertiary hospital in Guangzhou, within the coastal Pearl River Delta of southern China, from 2010 to 2021. Among 197 C. parapsilosis species-complex isolates, 17 were confirmed as C. orthopsilosis , including six bloodstream isolates. Nuclear and mitochondrial genome analyses assigned one highly homozygous isolate, BS03, to parent B, a lineage previously represented only by marine isolates. A blood culture yielding BS03 was collected after 12 days of ongoing caspofungin therapy. The patient developed septic shock and died two days later. In a Galleria mellonella model, BS03 showed pathogenic potential without significantly greater virulence than the tested fungal comparators. Its caspofungin MIC was 0.5 mg/L, within the wild-type range. Population analysis profiling nevertheless detected resistant subpopulations at 2, 4, and 8 mg/L caspofungin, corresponding to 4×, 8×, and 16× MIC, respectively. BS03 thus fulfilled the predefined criterion for caspofungin heteroresistance. Comparison of GSC1 ( FKS1 ), GSL1 , and GSL2 identified no BS03-specific canonical Fks1 hot spot resistance substitution. Conclusions: These findings extend the known clinical spectrum of C. orthopsilosis parent B beyond its previously recognised marine context. The coexistence of a wild-type-range caspofungin MIC with a resistant minority population further highlights within-isolate heterogeneity as an additional dimension of echinocandin susceptibility that may be missed by population-level MIC testing. Clinical trial number: Not applicable.
- Open Access
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1982885
Species distribution and antifungal susceptibility profiles of Trichosporon species: a multicenter study of 223 clinical isolates from South China
Background: Trichosporon species have emerged as opportunistic pathogens, causing life-threatening invasive infections. However, epidemiological data from South China remain limited. This multicenter study investigates the species distribution, genotypic characteristics, and antifungal susceptibility profiles of clinical Trichosporon isolates from this region. Methods: A total of 223 unique clinical Trichosporon isolates were collected from 18 centers in five South China provinces. These isolates were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and sequencing of the intergenic spacer 1 ( IGS1 ) region. The Trichosporon asahii isolates were further analyzed through IGS1 sequence analysis for genotyping. The minimum inhibitory concentrations (MICs) of six antifungal agents were determined using the broth microdilution method outlined by the Clinical and Laboratory Standards Institute (CLSI). Whole-genome sequencing (WGS) was performed on isolates with high fluconazole MICs and on randomly selected low-MIC isolates to characterize ERG11 mutations. Results: IGS1 sequencing identified 220 of the 223 isolates to the species level, representing eight species, with T. asahii predominating (171, 77.7%). The species-level concordance between MALDI-TOF MS and IGS1 sequencing was 85.5% (188/220), with substantial interspecies variation. Genotypes 1 (32.7%) and 3 (32.2%) co-predominated among T. asahii isolates, with no significant association found between genotype and specimen source (P = 0.663). Voriconazole was the most active agent, with a MIC 90 of 0.125 μg/mL and a geometric mean (GM) of 0.06 μg/mL. High fluconazole MICs were consistently associated with specific ERG11 substitutions: Y133F in T. dohaense and L229I, V132A, and Y133F in T. asteroides. Conclusions: T. asahii is the predominant clinical Trichosporon species in South China. Voriconazole is the most effective antifungal agent against Trichosporon . Species-specific ERG11 polymorphisms may be associated with elevated fluconazole MICs.
- 23 October 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1982885
Open AccessSpecies distribution and antifungal susceptibility profiles of Trichosporon species: a multicenter study of 223 clinical isolates from South China
Background: Trichosporon species have emerged as opportunistic pathogens, causing life-threatening invasive infections. However, epidemiological data from South China remain limited. This multicenter study investigates the species distribution, genotypic characteristics, and antifungal susceptibility profiles of clinical Trichosporon isolates from this region. Methods: A total of 223 unique clinical Trichosporon isolates were collected from 18 centers in five South China provinces. These isolates were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and sequencing of the intergenic spacer 1 ( IGS1 ) region. The Trichosporon asahii isolates were further analyzed through IGS1 sequence analysis for genotyping. The minimum inhibitory concentrations (MICs) of six antifungal agents were determined using the broth microdilution method outlined by the Clinical and Laboratory Standards Institute (CLSI). Whole-genome sequencing (WGS) was performed on isolates with high fluconazole MICs and on randomly selected low-MIC isolates to characterize ERG11 mutations. Results: IGS1 sequencing identified 220 of the 223 isolates to the species level, representing eight species, with T. asahii predominating (171, 77.7%). The species-level concordance between MALDI-TOF MS and IGS1 sequencing was 85.5% (188/220), with substantial interspecies variation. Genotypes 1 (32.7%) and 3 (32.2%) co-predominated among T. asahii isolates, with no significant association found between genotype and specimen source (P = 0.663). Voriconazole was the most active agent, with a MIC 90 of 0.125 μg/mL and a geometric mean (GM) of 0.06 μg/mL. High fluconazole MICs were consistently associated with specific ERG11 substitutions: Y133F in T. dohaense and L229I, V132A, and Y133F in T. asteroides. Conclusions: T. asahii is the predominant clinical Trichosporon species in South China. Voriconazole is the most effective antifungal agent against Trichosporon . Species-specific ERG11 polymorphisms may be associated with elevated fluconazole MICs.
- Open Access
- 1 July 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-11
Clinical and Epidemiologic Characteristics of Anaerobic Bacteria Originating from Blood Cultures: A Five-Year Retrospective Study
Background: With the rise of anaerobic bacteremia and resistance to anaerobes for commonly used agents, the resistance patterns of many anaerobes have changed significantly among different geographic areas and medical facilities. This study investigated the clinical and epidemiologic characteristics of anaerobic bacteremia for therapeutic optimization at the local level. Methods: This retrospective observational study included all positive blood cultures (BC) from 2020 to 2024. For patients with anaerobic bacteria originating from BCs, clinical and microbiological data were collected. Results: In total, 239 anaerobic strains were isolated from 223 patients. Among BC-positive bacteria, the proportion of anaerobes accounted for 4.4% (239/5450), with a gradual increase from 3.0% in 2020 to 6.1% in 2024. The most common anaerobes were Bacteroides fragilis (34.7%) and Cutibacterium acnes (20.5%). The resistance rates of gram-negative anaerobes to penicillin, imipenem, and meropenem were 94.4%, 21.1%, and 35.2%, respectively, which were much higher than those of gram-positive anaerobes (16.7%, 0%, 0%). Among the 223 cases, abdominal disorders were the most frequent underlying condition (54.7%). In the empirical antibiotic therapy, 94.6% of the patients received β-lactam antibiotics, and the infection symptoms improved in 74.9% of the patients. For Bacteroides spp. bacteremia, the improvement rate in patients treated with carbapenems and β-lactam/β-lactamase inhibitor combinations was 78.1% and 40.0%, respectively. Conclusion: The study presents valuable data for monitoring and improving anaerobic bacteremia treatment in Southern of China.
- 1 July 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-11
Open AccessClinical and Epidemiologic Characteristics of Anaerobic Bacteria Originating from Blood Cultures: A Five-Year Retrospective Study
Background: With the rise of anaerobic bacteremia and resistance to anaerobes for commonly used agents, the resistance patterns of many anaerobes have changed significantly among different geographic areas and medical facilities. This study investigated the clinical and epidemiologic characteristics of anaerobic bacteremia for therapeutic optimization at the local level. Methods: This retrospective observational study included all positive blood cultures (BC) from 2020 to 2024. For patients with anaerobic bacteria originating from BCs, clinical and microbiological data were collected. Results: In total, 239 anaerobic strains were isolated from 223 patients. Among BC-positive bacteria, the proportion of anaerobes accounted for 4.4% (239/5450), with a gradual increase from 3.0% in 2020 to 6.1% in 2024. The most common anaerobes were Bacteroides fragilis (34.7%) and Cutibacterium acnes (20.5%). The resistance rates of gram-negative anaerobes to penicillin, imipenem, and meropenem were 94.4%, 21.1%, and 35.2%, respectively, which were much higher than those of gram-positive anaerobes (16.7%, 0%, 0%). Among the 223 cases, abdominal disorders were the most frequent underlying condition (54.7%). In the empirical antibiotic therapy, 94.6% of the patients received β-lactam antibiotics, and the infection symptoms improved in 74.9% of the patients. For Bacteroides spp. bacteremia, the improvement rate in patients treated with carbapenems and β-lactam/β-lactamase inhibitor combinations was 78.1% and 40.0%, respectively. Conclusion: The study presents valuable data for monitoring and improving anaerobic bacteremia treatment in Southern of China.
- Open Access
- 20 August 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-9
Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China
Infections caused by Candida glabrata have raised increasing concerns, particularly due to the increasing resistance to echinocandins. This study investigated echinocandins susceptibility trends in C. glabrata isolates and explored the mechanisms driving resistance. We analyzed 418 strains of C. glabrata derived from hospitalized patients. Phenotypic resistance was assessed, and genotypic analysis was performed to identify mutations in the hotspot-1 and hotspot-2 regions of the FKS1 and FKS2 genes. Additionally, genotyping was conducted using multilocus sequence typing (MLST). The resistance rates to caspofungin, anidulafungin, and micafungin were 5.0%, 3.8%, and 4.0%, respectively, while fluconazole resistance was observed in 9.6% of the strains. Notably, 1.0% of the strains demonstrated resistance to both fluconazole and echinocandins. Mutations in the FKS genes were identified in 11 strains, predominantly in the FKS2-HS1 region. The most prevalent mutation was the F659 deletion (54.54%, 6/11), followed by S663F (18.18%, 2/11). Other mutations, including F659S, F659Y, and S663P, were also detected. These 11 mutated strains were classified into six distinct sequence types (STs), with ST208 being the most prevalent. The resistance rate of C. glabrata to echinocandins has been increasing annually in Guangdong province. Echinocandin resistance is associated with mutations in the FKS2 gene.
- 20 August 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-9
Open AccessPrevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China
Infections caused by Candida glabrata have raised increasing concerns, particularly due to the increasing resistance to echinocandins. This study investigated echinocandins susceptibility trends in C. glabrata isolates and explored the mechanisms driving resistance. We analyzed 418 strains of C. glabrata derived from hospitalized patients. Phenotypic resistance was assessed, and genotypic analysis was performed to identify mutations in the hotspot-1 and hotspot-2 regions of the FKS1 and FKS2 genes. Additionally, genotyping was conducted using multilocus sequence typing (MLST). The resistance rates to caspofungin, anidulafungin, and micafungin were 5.0%, 3.8%, and 4.0%, respectively, while fluconazole resistance was observed in 9.6% of the strains. Notably, 1.0% of the strains demonstrated resistance to both fluconazole and echinocandins. Mutations in the FKS genes were identified in 11 strains, predominantly in the FKS2-HS1 region. The most prevalent mutation was the F659 deletion (54.54%, 6/11), followed by S663F (18.18%, 2/11). Other mutations, including F659S, F659Y, and S663P, were also detected. These 11 mutated strains were classified into six distinct sequence types (STs), with ST208 being the most prevalent. The resistance rate of C. glabrata to echinocandins has been increasing annually in Guangdong province. Echinocandin resistance is associated with mutations in the FKS2 gene.
- Open Access
- 18 July 2025
- Published by Springer Nature in Mycopathologia
- Vol. 190 (4) , 65
Clinical and Molecular Epidemiological Characteristics of 26 Bloodstream Infection Cases Caused by Candida tropicalis
This study aims to investigate the clinical and molecular epidemiological characteristics of bloodstream infections caused by Candida tropicalis. This retrospective study analyzed the clinical data of patients diagnosed with C. tropicalis bloodstream infections from January 2020 to December 2022. Antifungal susceptibility testing was performed. Multilocus sequence typing (MLST) was used to analyze strain homology, and mutation analysis of the ERG11 (azole resistance-associated) and FKS1 (echinocandin resistance-associated) genes was conducted. Among the 26 cases of C. tropicalis bloodstream infections, hematologic malignancies were the most common underlying condition, with an overall mortality rate of 38.5%. Resistance rates to voriconazole and fluconazole were 30.8%, while the isolates exhibited high susceptibility to echinocandin drugs and amphotericin B. All fluconazole-resistant strains contained mutations in the ERG11 gene, with Y132F and S154F being the most frequent mutation sites. The mortality rate in fluconazole-resistant patients (37.5%) was similar to that of susceptible or dose-dependently susceptible patients (38.8%). A total of 20 distinct sequence types (DSTs) were identified among the 26 strains, all of which were previously known, indicating significant genetic diversity. The most abundant type was DST376. Hematologic malignancies are the most common underlying disease of C. tropicalis bloodstream infections. The isolated strains demonstrate significant genetic diversity and a high level resistance to fluconazole.
- 18 July 2025
- Published by Springer Nature in Mycopathologia
- Vol. 190 (4) , 65
Open AccessClinical and Molecular Epidemiological Characteristics of 26 Bloodstream Infection Cases Caused by Candida tropicalis
This study aims to investigate the clinical and molecular epidemiological characteristics of bloodstream infections caused by Candida tropicalis. This retrospective study analyzed the clinical data of patients diagnosed with C. tropicalis bloodstream infections from January 2020 to December 2022. Antifungal susceptibility testing was performed. Multilocus sequence typing (MLST) was used to analyze strain homology, and mutation analysis of the ERG11 (azole resistance-associated) and FKS1 (echinocandin resistance-associated) genes was conducted. Among the 26 cases of C. tropicalis bloodstream infections, hematologic malignancies were the most common underlying condition, with an overall mortality rate of 38.5%. Resistance rates to voriconazole and fluconazole were 30.8%, while the isolates exhibited high susceptibility to echinocandin drugs and amphotericin B. All fluconazole-resistant strains contained mutations in the ERG11 gene, with Y132F and S154F being the most frequent mutation sites. The mortality rate in fluconazole-resistant patients (37.5%) was similar to that of susceptible or dose-dependently susceptible patients (38.8%). A total of 20 distinct sequence types (DSTs) were identified among the 26 strains, all of which were previously known, indicating significant genetic diversity. The most abundant type was DST376. Hematologic malignancies are the most common underlying disease of C. tropicalis bloodstream infections. The isolated strains demonstrate significant genetic diversity and a high level resistance to fluconazole.
- Open Access
- 7 January 2024
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 13 (1) , 2300525
First report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia
Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.
- 7 January 2024
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 13 (1) , 2300525
Open AccessFirst report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia
Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.
- Open Access
- 18 September 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (9) , 2248
The Association of Organ Preservation Fluid Pathogens with Early Infection-Related Events after Kidney Transplantation
(1) Background: The need to elucidate the microbial patterns in preservation fluid and explore their relationship with early infection-related events post kidney transplant and investigate antimicrobial resistance and the effects of preemptive antibiotic therapy. (2) Methods: This retrospective study analyzed the clinical data of 514 kidney transplant donors and 808 recipients from April 2015 to October 2020. Clinical data of donor and recipient characteristics, preservation fluid microbes, early infections (≤30 days), probable donor-derived infections (P-DDIs), antimicrobial resistance and preemptive antibiotic therapy was collected. (3) Results: The incidence of bloodstream (10.3% versus 5.2%, p = 0.006) and graft-site infections (9.7% versus 4.6%, p = 0.004) was significantly higher in recipients with culture-positive preservation fluid. In addition, recipients with ESKAPE pathogens or Candida species had a notably higher rate of bloodstream infections (14.1% versus 6.9%, p = 0.033) and graft-site infections (16.7% versus 3.5%, p < 0.01) than those with other positive pathogens. Preemptive antibiotic therapy decreased the bloodstream infection rate (11.8% versus 35.7%, p = 0.047) when preservation fluid was positive for ESKAPE pathogens. (4) Conclusions: Culture-positive preservation fluid has potential implications for kidney transplant recipients. ESKAPE pathogens or Candida species in preservation fluid as well as their antimicrobial resistance properties and non-preemptive antibiotic therapy could pose a risk of early infection-related events.
- 18 September 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (9) , 2248
Open AccessThe Association of Organ Preservation Fluid Pathogens with Early Infection-Related Events after Kidney Transplantation
(1) Background: The need to elucidate the microbial patterns in preservation fluid and explore their relationship with early infection-related events post kidney transplant and investigate antimicrobial resistance and the effects of preemptive antibiotic therapy. (2) Methods: This retrospective study analyzed the clinical data of 514 kidney transplant donors and 808 recipients from April 2015 to October 2020. Clinical data of donor and recipient characteristics, preservation fluid microbes, early infections (≤30 days), probable donor-derived infections (P-DDIs), antimicrobial resistance and preemptive antibiotic therapy was collected. (3) Results: The incidence of bloodstream (10.3% versus 5.2%, p = 0.006) and graft-site infections (9.7% versus 4.6%, p = 0.004) was significantly higher in recipients with culture-positive preservation fluid. In addition, recipients with ESKAPE pathogens or Candida species had a notably higher rate of bloodstream infections (14.1% versus 6.9%, p = 0.033) and graft-site infections (16.7% versus 3.5%, p < 0.01) than those with other positive pathogens. Preemptive antibiotic therapy decreased the bloodstream infection rate (11.8% versus 35.7%, p = 0.047) when preservation fluid was positive for ESKAPE pathogens. (4) Conclusions: Culture-positive preservation fluid has potential implications for kidney transplant recipients. ESKAPE pathogens or Candida species in preservation fluid as well as their antimicrobial resistance properties and non-preemptive antibiotic therapy could pose a risk of early infection-related events.
- 15 June 2021
- Published by Springer Nature in Mycopathologia
- Vol. 186 (3) , 449-459
Vacuum-Assisted Closure and Skin Grafting Combined with Amphotericin B for Successful Treatment of an Immunocompromised Patient with Cutaneous Mucormycosis Caused by Mucor irregularis: A Case Report and Literature Review
Cutaneous mucormycosis caused by Mucor irregularis (M. irregularis) is a rare condition that typically occurs in immunocompetent patients. Herein, we describe an immunocompromised patient with cutaneous M. irregularis infection who was successfully treated with debridement combined with vacuum assisted closure (VAC) negative pressure technique and split-thickness skin grafting. We present this case owing to its complexity and rarity and the successful treatment with surgical therapy. A 58-year-old man presented to our hospital with a history of skin ulcers and eschar on the right lower leg since two months. He had been receiving methylprednisolone therapy for bullous pemphigoid that occurred five months prior to the present lesions. Histopathological examination of a right leg lesion showed broad, branching hyphae in the dermis. Fungal culture and subsequent molecular cytogenetic analysis identified the pathogen as M. irregularis. After admission, methylprednisolone was gradually tapered and systemic treatment with amphotericin B (total dose 615 mg) initiated along with others supportive therapies. However, the ulcers showed no improvement, and amphotericin B had to be discontinued owing to development of renal dysfunction. After extensive surgical debridement combined with VAC and skin grafting, his skin ulcers were healed; subsequent fungal cultures of the lesions were negative. The patient exhibited no signs of recurrence at 36-month follow-up. Twenty-six cases with M. irregularis-associated cutaneous mucormycosis in literature were reviewed.
- 15 June 2021
- Published by Springer Nature in Mycopathologia
- Vol. 186 (3) , 449-459
Vacuum-Assisted Closure and Skin Grafting Combined with Amphotericin B for Successful Treatment of an Immunocompromised Patient with Cutaneous Mucormycosis Caused by Mucor irregularis: A Case Report and Literature Review
Cutaneous mucormycosis caused by Mucor irregularis (M. irregularis) is a rare condition that typically occurs in immunocompetent patients. Herein, we describe an immunocompromised patient with cutaneous M. irregularis infection who was successfully treated with debridement combined with vacuum assisted closure (VAC) negative pressure technique and split-thickness skin grafting. We present this case owing to its complexity and rarity and the successful treatment with surgical therapy. A 58-year-old man presented to our hospital with a history of skin ulcers and eschar on the right lower leg since two months. He had been receiving methylprednisolone therapy for bullous pemphigoid that occurred five months prior to the present lesions. Histopathological examination of a right leg lesion showed broad, branching hyphae in the dermis. Fungal culture and subsequent molecular cytogenetic analysis identified the pathogen as M. irregularis. After admission, methylprednisolone was gradually tapered and systemic treatment with amphotericin B (total dose 615 mg) initiated along with others supportive therapies. However, the ulcers showed no improvement, and amphotericin B had to be discontinued owing to development of renal dysfunction. After extensive surgical debridement combined with VAC and skin grafting, his skin ulcers were healed; subsequent fungal cultures of the lesions were negative. The patient exhibited no signs of recurrence at 36-month follow-up. Twenty-six cases with M. irregularis-associated cutaneous mucormycosis in literature were reviewed.
- Open Access
- 30 May 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 1-10
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
The clonal spread of multiple drug-resistant Acinetobacter baumannii is an emerging problem in China. We analysed the molecular epidemiology of Acinetobacter baumanni isolates at three teaching hospitals and investigated the risk factors, clinical features, and outcomes of hospital-acquired pneumonia caused by extensive drug-resistant Acinetobacter baumannii (XDRAB) infection in Guangzhou, China. Fifty-two A. baumannii isolates were collected. Multilocus sequence typing (MLST) was used to assess the genetic relationships among the isolates. The bla OXA-51-like gene was amplified using polymerase chain reaction (PCR) and sequencing. The resistance phenotypes were determined using the disc diffusion method. A retrospective case-control study was performed to determine factors associated with XDRAB pneumonia. Most of the 52 A. baumannii isolates (N = 37, 71.2%) were collected from intensive care units (ICUs). The respiratory system was the most common bodily site from which A. baumannii was recovered (N = 45, 86.5%). Disc diffusion classified the isolates into 17 multidrug-resistant (MDR) and 35 extensively drug-resistant (XDR) strains. MLST grouped the A. baumannii isolates into 5 existing sequence types (STs) and 7 new STs. ST195 and ST208 accounted for 69.2% (36/52) of the isolates. The clonal relationship analysis showed that ST195 and ST208 belonged to clonal complex (CC) 92. According to the sequence-based typing (SBT) of the bla OXA-51-like gene, 51 A. baumannii isolates carried OXA-66 and the rest carried OXA-199. There were no significant differences with respect to the resistance phenotype between the CC92 and non-CC92 strains (P = 0.767). The multivariate analysis showed that the APACHE II score, chronic obstructive pulmonary disease (COPD) and cardiac disease were independent risk factors for XDRAB pneumonia (P < 0.05). The mortality rate of XDRAB pneumonia was high (up to 42.8%), but pneumonia caused by XDRAB was not associated with in-hospital mortality (P = 0.582). ST195 may be the most common ST in Guangzhou, China, and may serve as a severe epidemic marker. SBT of bla OXA-51-like gene variants may not result in sufficient dissimilarities to type isolates in a small-scale, geographically restricted study of a single region. XDRAB pneumonia was strongly related to systemic illnesses and the APACHE II score but was not associated with in-hospital mortality.
- 30 May 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 1-10
Open AccessPneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality
The clonal spread of multiple drug-resistant Acinetobacter baumannii is an emerging problem in China. We analysed the molecular epidemiology of Acinetobacter baumanni isolates at three teaching hospitals and investigated the risk factors, clinical features, and outcomes of hospital-acquired pneumonia caused by extensive drug-resistant Acinetobacter baumannii (XDRAB) infection in Guangzhou, China. Fifty-two A. baumannii isolates were collected. Multilocus sequence typing (MLST) was used to assess the genetic relationships among the isolates. The bla OXA-51-like gene was amplified using polymerase chain reaction (PCR) and sequencing. The resistance phenotypes were determined using the disc diffusion method. A retrospective case-control study was performed to determine factors associated with XDRAB pneumonia. Most of the 52 A. baumannii isolates (N = 37, 71.2%) were collected from intensive care units (ICUs). The respiratory system was the most common bodily site from which A. baumannii was recovered (N = 45, 86.5%). Disc diffusion classified the isolates into 17 multidrug-resistant (MDR) and 35 extensively drug-resistant (XDR) strains. MLST grouped the A. baumannii isolates into 5 existing sequence types (STs) and 7 new STs. ST195 and ST208 accounted for 69.2% (36/52) of the isolates. The clonal relationship analysis showed that ST195 and ST208 belonged to clonal complex (CC) 92. According to the sequence-based typing (SBT) of the bla OXA-51-like gene, 51 A. baumannii isolates carried OXA-66 and the rest carried OXA-199. There were no significant differences with respect to the resistance phenotype between the CC92 and non-CC92 strains (P = 0.767). The multivariate analysis showed that the APACHE II score, chronic obstructive pulmonary disease (COPD) and cardiac disease were independent risk factors for XDRAB pneumonia (P < 0.05). The mortality rate of XDRAB pneumonia was high (up to 42.8%), but pneumonia caused by XDRAB was not associated with in-hospital mortality (P = 0.582). ST195 may be the most common ST in Guangzhou, China, and may serve as a severe epidemic marker. SBT of bla OXA-51-like gene variants may not result in sufficient dissimilarities to type isolates in a small-scale, geographically restricted study of a single region. XDRAB pneumonia was strongly related to systemic illnesses and the APACHE II score but was not associated with in-hospital mortality.
- Open Access
- 12 April 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 271
Bacteremia caused by Bergeyella zoohelcum in an infective endocarditis patient: case report and review of literature
Bergeyella zoohelcum is an aerobic, Gram-negative bacterium that is frequently isolated from the upper respiratory tract of dogs, cats and other mammals. Clinically, B. zoohelcum has been reported causing cellulitis, tenosynovitis, leg abscess and septicemia, which is closely connected with animal bites. Here we describe a case of bacteremia in an infective endocarditis (IE) patient caused by B. zoohelcum, in China. A 27-year-old infective endocarditis woman who had no history of dog bite nor other mammal exposure suffered bacteremia caused by B. zoohelcum. This patient, without evidence of polymicrobial infection, was treated with cefuroxime and had a good outcome. B. zoolhelcum bacteremia is rarely reported in IE patients. Our report expands the range of known bacterial causes of infective endocarditis.
- 12 April 2017
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 17 (1) , 271
Open AccessBacteremia caused by Bergeyella zoohelcum in an infective endocarditis patient: case report and review of literature
Bergeyella zoohelcum is an aerobic, Gram-negative bacterium that is frequently isolated from the upper respiratory tract of dogs, cats and other mammals. Clinically, B. zoohelcum has been reported causing cellulitis, tenosynovitis, leg abscess and septicemia, which is closely connected with animal bites. Here we describe a case of bacteremia in an infective endocarditis (IE) patient caused by B. zoohelcum, in China. A 27-year-old infective endocarditis woman who had no history of dog bite nor other mammal exposure suffered bacteremia caused by B. zoohelcum. This patient, without evidence of polymicrobial infection, was treated with cefuroxime and had a good outcome. B. zoolhelcum bacteremia is rarely reported in IE patients. Our report expands the range of known bacterial causes of infective endocarditis.